BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15780553)

  • 1. Thrombomodulin: tumour biology and prognostic implications.
    Hanly AM; Hayanga A; Winter DC; Bouchier-Hayes DJ
    Eur J Surg Oncol; 2005 Apr; 31(3):217-20. PubMed ID: 15780553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of thrombomodulin in malignancy.
    Hanly AM; Winter DC
    Semin Thromb Hemost; 2007 Oct; 33(7):673-9. PubMed ID: 18000794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.
    Séguin C; Abid MR; Spokes KC; Aird WC
    Endothelium; 2008; 15(3):143-8. PubMed ID: 18568955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vitamin E Analog Gamma-Tocotrienol (GT3) and Statins Synergistically Up-Regulate Endothelial Thrombomodulin (TM).
    Pathak R; Ghosh SP; Zhou D; Hauer-Jensen M
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect.
    Bouton MC; Venisse L; Richard B; Pouzet C; Arocas V; Jandrot-Perrus M
    Circ Res; 2007 Apr; 100(8):1174-81. PubMed ID: 17379830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombomodulin: from haemostasis to inflammation and tumourigenesis.
    Koutsi A; Papapanagiotou A; Papavassiliou AG
    Int J Biochem Cell Biol; 2008; 40(9):1669-73. PubMed ID: 17709273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells.
    Eto M; Rathgeb L; Cosentino F; Kozai T; Lüscher TF
    J Cardiovasc Pharmacol; 2006 May; 47(5):663-7. PubMed ID: 16775505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells.
    Nan B; Yang H; Yan S; Lin PH; Lumsden AB; Yao Q; Chen C
    Surgery; 2005 Aug; 138(2):212-22. PubMed ID: 16153429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of prothrombin, thrombin and its receptors in human scars.
    Artuc M; Hermes B; Algermissen B; Henz BM
    Exp Dermatol; 2006 Jul; 15(7):523-9. PubMed ID: 16761961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model.
    Li YH; Liu SL; Shi GY; Tseng GH; Liu PY; Wu HL
    Thromb Haemost; 2006 Jan; 95(1):128-33. PubMed ID: 16543971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remodeling of carotid arteries is associated with increased expression of thrombomodulin in a mouse transverse aortic constriction model.
    Li YH; Hsieh CY; Wang DL; Chung HC; Liu SL; Chao TH; Shi GY; Wu HL
    Thromb Haemost; 2007 Apr; 97(4):658-64. PubMed ID: 17393030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins in tumor suppression.
    Sassano A; Platanias LC
    Cancer Lett; 2008 Feb; 260(1-2):11-9. PubMed ID: 18180097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.
    Scaldaferri F; Sans M; Vetrano S; Graziani C; De Cristofaro R; Gerlitz B; Repici A; Arena V; Malesci A; Panes J; Grinnell BW; Danese S
    J Clin Invest; 2007 Jul; 117(7):1951-60. PubMed ID: 17557119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells.
    Sen-Banerjee S; Mir S; Lin Z; Hamik A; Atkins GB; Das H; Banerjee P; Kumar A; Jain MK
    Circulation; 2005 Aug; 112(5):720-6. PubMed ID: 16043642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombomodulin enhances the invasive activity of mouse mammary tumor cells.
    Niimi S; Harashima M; Takayama K; Hara M; Hyuga M; Seki T; Ariga T; Kawanishi T; Hayakawa T
    J Biochem; 2005 May; 137(5):579-86. PubMed ID: 15944410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of thrombomodulin in malignant pleural mesothelioma].
    Amati M; Nocchi I; Tomasetti M; Santarelli L; Saccucci F
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):99-102. PubMed ID: 23393812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.